美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Astellas Pharma, Inc.

14.66

-0.1100-0.74%

成交量：11.90萬

成交額：175.00萬

市值：262.46億

市盈率：197.17

高：14.88

開：14.82

低：14.65

收：14.77

52周最高：16.95

52周最低：8.37

股本：17.90億

流通股本：17.45億

量比：0.90

換手率：0.01%

股息：0.51

股息率：3.50%

每股收益(TTM):0.0744

每股收益(LYR):0.0628

淨資產收益率：19.82%

總資產收益率：7.38%

市淨率：2.38

市盈率(LYR):233.29

資料載入中...

總覽公司新聞資訊公告

安斯泰來：EV-304研究中圍術期enfortumab vedotin聯合帕博利珠單抗的安全性特徵與既往聯合用藥經驗一致

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ALPMY/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ALPMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMY\",,,,,undefined,":{"symbol":"ALPMY","market":"US","secType":"STK","nameCN":"Astellas Pharma, Inc.","latestPrice":14.66,"timestamp":1773432000000,"preClose":14.77,"halted":0,"volume":119032,"delay":15,"changeRate":-0.007447528774542954,"floatShares":1745183156,"shares":1790310070,"eps":0.074352,"marketStatus":"盤後交易","change":-0.11,"latestTime":"03-13 16:00:00 EDT 延時","open":14.82,"high":14.8815,"low":14.65,"amount":1750007.27368,"amplitude":0.015674,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.074352,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1773446400000},"marketStatusCode":4,"adr":0,"adrRate":1,"exchange":"PINK LIMITED","adjPreClose":14.77,"volumeRatio":0.902102},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMY\",,,,,undefined,":{"symbol":"ALPMY","floatShares":1745183156,"roa":"7.38%","roe":"19.82%","lyrEps":0.062841,"volumeRatio":0.902102,"shares":1790310070,"dividePrice":0.5133,"high":14.8815,"amplitude":0.015674,"preClose":14.77,"low":14.65,"week52Low":8.37,"pbRate":"2.38","psRate":"2.03","week52High":16.95,"institutionHeld":0,"latestPrice":14.66,"eps":0.074352,"divideRate":0.035014,"volume":119032,"delay":15,"ttmEps":0.074352,"open":14.82,"prevYearClose":13.29,"prevWeekClose":14.93,"prevMonthClose":16.51,"prevQuarterClose":13.29,"fiveDayClose":14.93,"twentyDayClose":16.06,"sixtyDayClose":13.58},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALPMY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-04","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"","actualEps":null},{"date":"2024-08-01","symbol":"ALPMY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722499200000,"name":null,"time":"","dateTimestamp":1722484800000,"actualEps":null},{"market":"US","date":"2024-04-25","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-05","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1707109200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-01","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1698811200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALPMY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALPMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1758254400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALPMY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1164144381","title":"安斯泰來：EV-304研究中圍術期enfortumab vedotin聯合帕博利珠單抗的安全性特徵與既往聯合用藥經驗一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1164144381","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164144381?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 23:05","pubTimestamp":1772204701,"startTime":"0","endTime":"0","summary":"根据EV-304研究数据，安斯泰来制药公司公布的最新结果显示，在围术期使用enfortumab vedotin联合帕博利珠单抗的治疗方案，其安全性特征与先前对该联合疗法的经验保持一致。\n这一发现进一步支持了该联合治疗方案在临床应用中的安全性一致性，为后续治疗策略的制定提供了重要参考依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","LU1023059063.AUD","LU0058720904.USD","IE000M9KFDE8.USD","LU0306806265.USD","BK4599","BK4550","SG9999011175.SGD","LU1894683348.USD","SGXZ57979304.SGD","ALPMY","IE0002270589.USD","LU1894683264.USD","BK4581","IE00BLSP4452.SGD","LU0321505868.SGD","BK4592","BK4007","LU0225771236.USD","SG9999013999.USD","SG9999002224.SGD","SG9999002232.USD","LU1057294990.SGD","SG9999003800.SGD","BK4534","LU0456855351.SGD","LU0306807586.USD","SG9999001176.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU1066051498.USD","BK4568","LU0122379950.USD","LU0985481810.HKD","LU0234572021.USD","LU0170899867.USD","LU0868494617.USD","BK4533","IE00BBT3K403.USD","IE00B19Z3B42.SGD","SG9999001176.SGD","IE00BLSP4239.USD","LU1883839398.USD","BK4585","LU0321505439.SGD","LU0225284248.USD","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}